Physiological Contribution of CD44 as a Ligand for E-Selectin during Inflammatory T-Cell Recruitment
Endothelial selectins guide the migration of inflammatory T cells to extralymphoid tissues. Whereas P-selectin glycoprotein ligand-1 (PSGL-1) functions as the exclusive ligand for P-selectin, it acts in coordination with additional glycoproteins to mediate E-selectin binding. CD44 can act as one such ligand in neutrophils, but its contribution in inflammatory T lymphocytes remains unexplored. We have used real-time in vivo imaging of the cremasteric and dermal microcirculations to explore the dynamics of leukocyte recruitment, as well as the physiological contribution of CD44 in a model of Th1-driven inflammation. CD4+ T-cell rolling frequency and kinetics, as well as arrest, were dependent on endothelial selectins and were markedly altered under inflammatory conditions. CD44 extracted from Th1 cells bound to soluble E-selectin in vitro and cooperated with PSGL-1 by controlling rolling velocities and promoting firm arrest. Using several competitive recruitment assays in a delayed-type hypersensitivity model, we show that the combined absence of CD44 and PSGL-1 impairs inflammatory T-cell recruitment beyond that of PSGL-1 alone. Differential expression of leukocyte fucosyltransferases in these cells may account for the differential use of E-selectin ligands relative to neutrophils. Our results identify additional mechanisms by which CD44 modulates the inflammatory response.
Supported by a Scientist Development grant from the American Heart Association to A.H. and U.S. National Institutes of Health grant R01 HL69438 to P.S.F (0735165N). A.H. is also supported by a Ramón y Cajal fellowship, a grant (SAF2009-11037) from the Spanish Ministry of Science and Innovation, and by a grant (246655) from the FP7-People-IRG Program. The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation.
Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.01.039.
Current address of C.P. and P.S.F., Institute of Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, New York, NY; of A.B.B., Fundación IMABIS, Malaga, Spain.
PII: S0002-9440(11)00148-9
doi:10.1016/j.ajpath.2011.01.039
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
